Hera Biotech, Inc. announced it raised $804,000 in an amended filing from an offering of $1.5 Million

Company

Location

About

Hera Biotech is a women’s health company dedicated to advancing the standard of care by addressing critical diagnostic and therapeutic deficiencies. With a vision to become the global leader in women’s health innovation, Hera’s first mission is to validate and commercialize the world’s first non-surgical method for diagnosing and staging endometriosis, transforming how this condition is detected and managed.